Doximity (DOCS) Shares Fall Amid Cautious Revenue Outlook

Author's Avatar
May 16, 2025
  • Doximity's (DOCS, Financial) stock plummeted by 14% following a cautious revenue outlook for Q1 and fiscal 2026.
  • Q4 FY25 revenue increased by 17% year-over-year to $138.3 million but fell short of market expectations.
  • Analysts anticipate a potential 34.82% upside, with an average price target of $67.07.

Doximity (DOCS) recently faced a steep 14% decline in its share price. This drop occurred after the company revealed a cautious revenue outlook for the upcoming quarter and fiscal year 2026. Despite a commendable 17% year-over-year rise in Q4 FY25 revenue to $138.3 million, the market was disappointed due to overarching macroeconomic uncertainties impacting future projections.

Wall Street Analysts' Price Targets

1923393313931685888.png

Based on projections from 17 analysts, Doximity Inc (DOCS, Financial) is projected to reach an average price target of $67.07 over the next year. This estimate spans from a high of $88.00 to a low of $50.00. With the current price standing at $49.75, this average target indicates a potential upside of 34.82%. Investors interested in more detailed estimates can explore the Doximity Inc (DOCS) Forecast page.

Brokerage Recommendations

Doximity Inc's (DOCS, Financial) average brokerage recommendation rests at 2.4, which aligns with an "Outperform" status based on input from 20 brokerage firms. In this rating system, 1 denotes a Strong Buy, whereas 5 signifies a Sell. This outlook suggests a favorable but cautious sentiment towards the stock.

GuruFocus GF Value Estimates

According to GuruFocus, the estimated GF Value for Doximity Inc (DOCS, Financial) in one year's time is $55.40. This suggests an upside potential of 11.36% from its current trading price of $49.75. The GF Value represents an estimate of the stock's fair trading value, calculated from historical trading multiples, past business growth, and future performance projections. For additional insights, investors can refer to the Doximity Inc (DOCS) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.